Related by context. Frequent words. (Click for all words.) 60 mixed dyslipidemia 60 cell malignancies 59 lupus nephritis 59 hypercholesterolemia 59 systemic lupus erythematosus 58 lipid disorders 58 investigational compounds 58 systemic lupus erythematosus SLE 57 hypercalcemia 57 fibrotic diseases 57 multiple sclerosis rheumatoid arthritis 57 Phenoptin 56 orally bioavailable 56 humanized anti 56 hematological cancers 56 immunological disorders 56 ELND# 56 rNAPc2 56 Hsp# inhibitors 56 BMN 56 therapeutic modalities 56 induce apoptosis 56 hematological malignancies 56 myelofibrosis 55 chronic HCV infection 55 tanespimycin 55 ophthalmic diseases 55 immunomodulators 55 muscular dystrophies 55 tyrosine kinase inhibitors 55 neuropsychiatric disorders 55 investigational compound 55 cardiovascular metabolic 55 diabetic nephropathy 55 humanized monoclonal antibody 55 diabetes cardiovascular disease 55 hepatocellular carcinoma HCC 55 aHUS 55 solid tumors 55 oncology indications 55 inflammatory bowel diseases 55 lymphoma CTCL 55 ocrelizumab 55 Genasense R oblimersen 54 cutaneous T cell 54 confirmatory Phase III 54 VQD 54 Acute Myeloid Leukemia AML 54 castration resistant prostate cancer 54 ophthalmic indications 54 SCH # 54 Allovectin 7 R 54 cancer cachexia 54 dyslipidemia 54 Drug Candidate 54 diabetic neuropathic pain 54 sodium Injection 54 ocular diseases 54 peripheral neuropathies 54 eculizumab 54 autoimmune disorders 54 ponatinib 54 potent inhibitor 54 talactoferrin 53 autoimmune diseases 53 myelodysplastic syndromes MDS 53 inflammatory autoimmune 53 Azedra 53 HspE7 53 hematologic cancers 53 lysosomal storage disorders 53 bafetinib 53 Initiates Phase 53 temsirolimus 53 relapsed refractory multiple myeloma 53 Asentar 53 von Willebrand disease 53 xenograft models 53 PS# [001] 53 #ME# 53 Phase IIa clinical trials 53 dose limiting toxicities 53 myelodysplastic syndrome MDS 53 ALN VSP 53 gastrointestinal cancers 53 androgen independent 53 hematologic malignancies 53 injectable formulation 53 chronic lymphocytic leukemia CLL 53 gastrointestinal stromal tumors 53 dasatinib 53 NGX# 53 vascular disorders 53 CRx 53 selective inhibitor 53 investigational drug 53 transcriptase inhibitor NNRTI 53 inflammatory diseases 53 hypoparathyroidism 53 candidiasis 52 immunomodulatory